Lv43
470 积分 2025-12-29 加入
Structural insight into selectivity of amylin and calcitonin receptor agonists
35分钟前
待确认
Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin
1天前
已完结
849-P: Eloralintide (LY3841136), a Selective Amylin Mimetic, Lowered Body Weight with Improved Quality of Weight Loss and GI Tolerability in Rats Compared with Cagrilintide
6天前
已完结
Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors
8天前
已完结
Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment
11天前
已完结
MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma
1个月前
已关闭
EFFECT OF GENETIC DISRUPTION OF POLY (ADP-RIBOSE) SYNTHETASE ON DELAYED PRODUCTION OF INFLAMMATORY MEDIATORS AND DELAYED NECROSIS DURING MYOCARDIAL ISCHEMIA-REPERFUSION INJURY
1个月前
已完结
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
2个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
2个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
2个月前
已完结
皖公网安备34019202002308
